Atlas Trials

Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber

Clinical trial NCT02874326 · UNKNOWN

Trial details

NCT number
NCT02874326
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Hemorrhagic TelangiectasiaGastrointestinal HemorrhageAnemia
Start date
2016-10-01
Primary completion
2018-07-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.